Conditions: Papulopustular Rosacea
Keywords: Papulopustular Rosacea Oracea anti inflammatory doxycycline
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 24
Healthy volunteers: no

Brief summary:
The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.

Detailed description:

Arms:
arm 1: Oracea (doxycycline USP, 40mg\[30mg immediate release/ 10mg delayed release beads\] taken once daily in the morning on an empty stomach, one hour before meals or two hours after.

Oral dose for 12 weeks

Interventions: intervention 1: Oracea
Intervention descriptions: intervention 1: None

Protocol document: